In past studies, we further found that elevated combined expression of MRE11 and ATM or of the entire MRN complex in the TC is associated with a worse prognosis and poor response to neoadjuvant radiotherapy in rectal cancer patients [28,29]. The gene discussed is MRE11; the disease is rectal cancer.